1Sturm D, Bender S, Jones DT, et al. Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge [ J ]. Nat Rev Cancer, 2014, 14(2) : 92 - 107.
2Chung AS, Wu X, Zhuang G, et al. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy [J~. Nat Med, 2013, 19(9) : 1114-1123.
3Chen ZJ. Ubiquitination in signaling to and activation of IKK [ J]. lmmunol Rev, 2012, 246(1): 95-106.
4Bertrand MJ, Milutinovic S, Dickson KM, et al. clAP1 and clAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination [J]. Mol Cell, 2008, 30(6): 689-700.
5Tada K, Okazaki T, Sakon S, et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and pro- tection from cell death [J]. J Biol Chem, 2001, 276(39) : 36530 - 36534.
6Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls [J]. Nat Rev Drug Discov, 2009, 8(1) : 33 -40.
7Salminen A, Ojala J, Kaarniranta K. Apoptosis and aging: increased resistance to apoptosis enhances the aging process [ J 1- Cell Mol Life Sci, 2011, 68(6): 102l -103l.
